Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Yuling Han, Xiaohua Duan, Liuliu Yang, Benjamin E. Nilsson-Payant, Pengfei Wang, Fuyu Duan, Xuming Tang, Tomer M. Yaron, Tuo Zhang, Skyler Uhl, Yaron Bram, Chanel Richardson, Jiajun Zhu, Zeping Zhao, David Redmond, Sean Houghton, Duc-Huy T. Nguyen, Dong Xu, Xing Wang, José Jessurun, Alain Borczuk, Yaoxing Huang, Jared L. Johnson, Yuru Liu, Jenny Xiang, Hui Wang, Lewis C. Cantley, Benjamin R. tenOever, David D. Ho, Fong Cheng Pan, Todd Evans, Huanhuan Joyce Chen, Robert E. Schwartz, Shuibing Chen
Topics & Concepts
Induced pluripotent stem cellOrganoidMedicineDrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)LungPharmacologyImmunologyBiologyDiseaseVirologyInternal medicineEmbryonic stem cellInfectious disease (medical specialty)GeneBiochemistryGeneticsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPancreatic function and diabetes